Full Press Release Details
Woburn, MA, Sept. 26, 2025 (GLOBE NEWSWIRE) --Biofrontera Inc., (Nasdaq:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced that it will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2025 Investor Conference, taking place virtually on Tuesday, September 30, 2025.
Company Webcast
The webcast presentation will take place at 1:15 p.m. ET on Tuesday, September 30, 2025. The webcast can be accessed by visiting the conference home page athttps://lythampartners.com/fall2025/or directly athttps://app.webinar.net/wWqPp4Yr0kD. The webcast will also be available for replay following the event.
1x1 Meetings
Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at1x1@lythampartners.comor register for the event athttps://lythampartners.com/fall2025invreg/.
About Biofrontera Inc.
Biofrontera Inc. is a U.S.-based biopharmaceutical company specializing in the development and treatment of dermatological conditions with a focus on PDT. The Company commercializes the drug-device combination Ameluz®with the RhodoLED®lamp series for PDT of AK, pre-cancerous skin lesions which may progress to invasive skin cancers. The Company performs clinical trials to extend the use of the products to treat non-melanoma skin cancers and moderate to severe acne. For more information, visitwww.biofrontera-us.comand follow Biofrontera onLinkedInandX.
Investor Relations Contact
Ben ShamsianLytham Partners646-829-9701shamsian@lythampartners.com